Continental Chemicals board to meet on May 30 for Q4FY26 results

1 min read     Updated on 20 May 2026, 02:09 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Continental Chemicals Limited announced that its board will meet on May 30, 2026, to consider the audited financial results for the fourth quarter and fiscal year ended March 31, 2026. The agenda includes the appointment of an internal auditor for FY27. The trading window for designated persons is closed from April 1, 2026, until 48 hours post-result announcement.

powered bylight_fuzz_icon
40811944

*this image is generated using AI for illustrative purposes only.

Continental Chemicals Limited has scheduled a board meeting for Saturday, May 30, 2026, at its registered office in Noida. The meeting will be convened pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015. The primary agenda includes the consideration and approval of the audited quarterly and yearly financial results for the period ended March 31, 2026.

Agenda for the Board Meeting

The board will review the financial performance for the fourth quarter of the fiscal year 2026. Alongside the results, the directors will consider the appointment of an internal auditor for the financial year 2026-2027. The meeting may also discuss any other matters with the permission of the chair.

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has informed its designated persons about the closure of the trading window. This restriction is effective from April 1, 2026, and will remain in place until 48 hours after the financial results are made public to the exchanges.

Meeting Details

The board meeting is set to take place at 3:00 P.M. The venue for the meeting is the company's registered office located at A-7, Sector-7, Noida-201301 (U.P.). The intimation regarding the trading window closure has already been submitted to the stock exchanges.

Historical Stock Returns for Continental Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+15.74%+11.44%-8.15%-4.89%+385.39%

How might Continental Chemicals Limited's FY2026 annual financial results compare to industry peers in the specialty chemicals sector, and what growth trajectory could they signal for FY2027?

What strategic priorities might the newly appointed internal auditor for FY2026-2027 focus on, given the current regulatory environment for listed chemical companies in India?

Could the board meeting's 'any other matters' agenda item potentially include announcements related to expansion plans, dividend declarations, or capital restructuring for Continental Chemicals?

like19
dislike

Continental Chemicals Limited Submits Quarterly Dematerialization Compliance Certificate for Q4 FY26

1 min read     Updated on 03 Apr 2026, 05:26 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Continental Chemicals Limited filed its quarterly dematerialization compliance certificate under SEBI Regulation 74(5) for Q4 FY26 on April 3, 2026. The certificate, submitted through registrar Beetal Financial and Computer Services, confirms proper processing of all dematerialization requests and adherence to regulatory timelines for the quarter ended March 31, 2026.

powered bylight_fuzz_icon
36762987

*this image is generated using AI for illustrative purposes only.

Continental chemicals has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The filing was made to the Bombay Stock Exchange on April 3, 2026, demonstrating the company's adherence to regulatory requirements for dematerialization processes.

Regulatory Compliance Filing

The certificate was filed through the company's registrar and transfer agent, Beetal Financial and Computer Services (P) Ltd, which holds SEBI registration number INR 000000262 as a category I registrar and share transfer agent. Company Secretary Sakshi Dhawan, with membership number ACS 33279, signed the submission on behalf of Continental Chemicals Limited.

Dematerialization Process Confirmation

Beetal Financial confirmed that all securities received from depository participants for dematerialization during the quarter ended March 2026 were properly processed and confirmed to the depositories. The registrar provided comprehensive assurance regarding the handling of dematerialization requests during this period.

Process Component: Status
Securities Processing: Confirmed to depositories
Stock Exchange Listing: Securities listed where earlier securities are listed
Certificate Handling: Mutilated and cancelled after verification
Register Updates: Depositories' names substituted within 15 days

Regulatory Framework

The filing references SEBI Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This regulation mandates quarterly confirmation certificates from registrar and transfer agents regarding dematerialization processes.

Company Information

Continental Chemicals Limited operates from its registered and head office located at A-7, Sector-7, Noida-201301, Uttar Pradesh. The company maintains its corporate identification number as L24123UP1984PLC014111 and trades on the Bombay Stock Exchange under scrip code 506935.

Historical Stock Returns for Continental Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+5.00%+15.74%+11.44%-8.15%-4.89%+385.39%

Will Continental Chemicals consider expanding its stock exchange listings beyond BSE to improve liquidity and market access?

How might upcoming changes to SEBI's dematerialization regulations in 2026-27 impact Continental Chemicals' compliance processes?

What operational improvements is Continental Chemicals planning to enhance its registrar and transfer agent relationships?

like15
dislike

More News on Continental Chemicals

1 Year Returns:-4.89%